Skip to content

13F-HR filed by SECTOR GAMMA AS

SECTOR GAMMA AS filed this 13F-HR for the quarter ended 2018-03-31, filed 2018-05-09, with 30 holding rows worth $554,860,000.

Accession
0001140361-18-022357
Filed
2018-05-09
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2018

A holdings report, 30 entries on the cover page, a total value of $554,860,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $554,860,000 with VALUE read as thousands by filing date, 13F file number 028-13612. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
Abbott Laboratories002824100COM1,105,642$66,250,000thousands by filing date
Boston Scientific Corporation101137107COM1,741,380$47,575,000thousands by filing date
BAXTER INTL INC071813109COM715,438$46,532,000thousands by filing date
Merck & Co.,Inc.58933Y105COM725,200$39,502,000thousands by filing date
REVVITY INC714046109COM378,206$28,638,000thousands by filing date
ASTRAZENECA PLC SPONSORED ADR046353108ADR806,035$28,187,000thousands by filing date
SHIRE PLC82481R106COMMON STOCK-FO164,975$24,646,000thousands by filing date
BIO RAD LABS INC090572207CL A94,240$23,568,000thousands by filing date
Bristol-Myers Squibb Company110122108COM362,006$22,897,000thousands by filing date
INTEGRA LIFESCIENCES HLDGS C457985208COM NEW386,966$21,415,000thousands by filing date
Eli Lilly and Company532457108COM252,514$19,537,000thousands by filing date
NUVASIVE INC670704105COM371,997$19,422,000thousands by filing date
Elevance Health, Inc.036752103COM85,910$18,874,000thousands by filing date
IRONWOOD PHARMACEUTICALS INC46333X108COMMON STOCK1,121,135$17,299,000thousands by filing date
CARDINAL HEALTH INC14149Y108COM226,263$14,182,000thousands by filing date
LABORATORY CORP OF AMERICA50540R409COM NEW84,400$13,652,000thousands by filing date
TENET HEALTHCARE CORP COM NEW88033G407Stock534,021$12,950,000thousands by filing date
IONIS PHARMACEUTICALS INC COM462222100Stock273,500$12,056,000thousands by filing date
PERRIGO CO PLC SHSG97822103Stock137,840$11,488,000thousands by filing date
ALLERGAN PLCG0177J108SHS64,300$10,821,000thousands by filing date
UNIVERSAL HLTH SVCS INC CL B913903100Stock86,973$10,298,000thousands by filing date
Gilead Sciences,Inc.375558103COM103,500$7,803,000thousands by filing date
LEXICON PHARMACEUTICALS INC528872302COMMON STOCK854,592$7,324,000thousands by filing date
PATTERSON COS INC703395103COM312,232$6,941,000thousands by filing date
CLOVIS ONCOLOGY INC189464100COM123,892$6,541,000thousands by filing date
PORTOLA PHARMACEUTICALS INC COM737010108Stock134,800$4,403,000thousands by filing date
SAREPTA THERAPEUTICS INC803607100COM51,006$3,779,000thousands by filing date
AGIOS PHARMACEUTICALS INC00847X104COM41,000$3,353,000thousands by filing date
SPARK THERAPEUTICS INC84652J103COM46,600$3,103,000thousands by filing date
SANGAMO THERAPEUTICS INC800677106COM96,000$1,824,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001140361-18-022357this filing2018-05-09acceptance time not in the bulk data set